The future of pharmacoeconomic policy - does value-based pricing really have a role?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The future of pharmacoeconomic policy - does value-based pricing really have a role?

Published:2016-01-28 Issue:1 Volume:7 Page:5-9
ISSN:1759-8885
Container-title:Journal of Pharmaceutical Health Services Research
language:en
Short-container-title:J Pharm Health Serv Res

Author:

Kiernan Fiona¹

Affiliation:

1. Department of Anaesthesia and Intensive Care Medicine; Beaumont Hospital; Royal College of Surgeons of Ireland; Dublin Ireland

Publisher

Oxford University Press (OUP)

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jphs.12126/fullpdf

Reference34 articles.

1. The value of medical spending in the United States, 1960-2000;Cutler;N Engl J Med,2006

2. National health spending projections through 2020: economic recovery and reform drive faster spending growth;Keehan;Health Affairs ProQuest Business Collection,2011

3. Examining the link between price regulation and pharmaceutical R&D investment;Vernon;Health Econ,2005

4. Two ideas to increase innovation and reduce pharmaceutical costs and prices;Jayadev;Health Affairs, ProQuest Business Collection,2009

5. Johannesson M et al Why should economic evaluations of medical innovations have a societal perspective? 2009 http://www.ohe.org/publications/article/why-should-economic-evaluations-of-medical-innovations-have-a-societal-perspective-27.cfm

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining ‘therapeutic value’ of medicines: a scoping review;BMJ Open;2023-12

2. The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approach;Expert Review of Pharmacoeconomics & Outcomes Research;2023-03-07

3. Value-based drug price schemes: a welfare analysis;Journal of Pharmaceutical Health Services Research;2021-08-30

4. Barriers and Opportunities for Implementation of Outcome-Based Spread Payments for High-Cost, One-Shot Curative Therapies;Frontiers in Pharmacology;2020-12-08

5. Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis;International Journal of Environmental Research and Public Health;2020-11-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3